Records containing: Stage I Multiple Myeloma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2016-12-19A Phase 2 Trial of Carfilzomib Consolidation After Autologous Stem Cell Transplantation for Multiple Myeloma(CARAMEL 2)
-
CLINICAL_TRIALS study record update · 2016-09-23A Phase I/II Trial of Cyclophosphamide, Carfilzomib, Thalidomide and Dexamethasone (CYCLONE) in Patients With Newly Diagnosed Active Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2016-08-08A Phase I/II Study of Flavopiridol Administered as a 30-Minute Bolus Followed by a 4-Hour Infusion in Lymphomas and Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2016-06-03A Phase II Randomized Study of Three Subcutaneous Bortezomib-based Consolidation Treatments for Patients Completing Induction Therapy and Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2015-12-04A Phase 1 Study of CCI-779 in Combination With Dexamethasone in Multiple Myeloma
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2015-06-26Randomized Phase III Trial of Consolidation Therapy With Bortezomib (Velcade®)-Lenalidomide (Revlimid®) -Dexamethasone (VRD) Versus Bortezomib (Velcade®)-Dexamethasone (VD) for Patients With Multiple Myeloma Who Have Completed a Dexamethasone Based Induction Regimen
-
CLINICAL_TRIALS study record update · 2015-04-24A Phase II Trial of Weekly Bortezomib and Dexamethasone With Oral Metronomic Cyclophosphamide in Elderly Patients With Plasma Cell Myeloma
-
CLINICAL_TRIALS study record update · 2014-04-02A Preliminary Study to Evaluate the Effects of Palifermin in Patients at Risk of Chronic Graft-versus-host Disease
-
CLINICAL_TRIALS study record update · 2013-12-16A Pilot Study Using High Dose Busulfan and Bortezomib as Part of Allogeneic Transplant Conditioning Regimen for High Risk Multiple Myeloma Patients.
-
CLINICAL_TRIALS study record update · 2013-12-09A Phase I/II Trial of Obatoclax Mesylate (GX15-070MS) in Combination With Bortezomib for the Treatment of Relapsed Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2013-11-27Impact of Intervention With Deferasirox on the Immune Function of Patients With Hematologic Diseases and Transfusion-Related Iron Overload
-
CLINICAL_TRIALS study record update · 2013-10-11A Phase II Trial of CCI-779 in Patients With Relapsed or Refractory Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2013-07-10Phase II Study of Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Patients With Previously Untreated High-Risk or Relapsed or Refractory Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2013-05-31The Treatment of Multiple Myeloma Utilizing VBMCP Chemotherapy Alternating With High-Dose Cyclophosphamide and Alpha2b-Interferon Versus VBMCP: A Phase III Study for Previously Untreated Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2013-03-27CTLA-4 Blockade With MDX-010 to Induce Graft-Versus-Malignancy Effects Following Allogeneic Hematopoietic Stem Cell Transplantation
-
CLINICAL_TRIALS study record update · 2013-03-06A Phase II Trial of Sunitinib (SU11248) in Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2013-02-15A Phase I/Pilot Study of Intravenous PLERIXAFOR Following Cyclophosphamide Mobilization in Patients With Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2013-02-07A Phase I Study of SAHA in Combination With Bortezomib in Relapsed and Refractory Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2013-01-16A Phase II Study of Flavopiridol in Patients With Relapsed and Refractory Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2012-09-28Phase II Study of PS-341 for Patients With High-Risk, Newly Diagnosed Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2012-07-30Phase II Trial of Intravenously Administered AMD3100 (Plerixafor) for Stem Cell Mobilization in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplantation Following a Lenalidomide Based Initial Therapy
-
CLINICAL_TRIALS study record update · 2012-03-07INSPIRE: An Internet-based RCT for Long-term Survivors of Hematopoietic Stem Cell Transplantation